Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study
Objective: To examine the effect of a 12-month pharmaceutical care (PC) program on vascular risk in type 2 diabetes. Research design and methods: We recruited 198 community-based patients randomized to PC or usual care. PC patients had face-to-face goal-directed medication and lifestyle counseling...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
American Diabetes Association
2005
|
| Online Access: | http://hdl.handle.net/20.500.11937/41001 |